{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TP1", "query": { "intervention": "TP1" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TP1&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-09T00:41:17.456Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05428774", "title": "Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fluid Retention", "Beverage Hydration Index", "Hydration Status" ], "interventions": [ { "name": "Test product 1", "type": "OTHER" }, { "name": "Test product 2", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Liquid I.V.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "MALE", "summary": "18 Years to 35 Years · Male only" }, "enrollment_count": 15, "start_date": "2022-08-01", "completion_date": "2023-01-01", "has_results": false, "last_update_posted_date": "2023-01-25", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05428774" }, { "nct_id": "NCT06293365", "title": "Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjögrens Disease", "Systemic Lupus Erythematosus", "Rheumatoid Arthritis" ], "interventions": [ { "name": "VAY736 1ml PFS", "type": "BIOLOGICAL" }, { "name": "VAY736 2 ml PFS", "type": "BIOLOGICAL" }, { "name": "VAY736 2ml AI", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 155, "start_date": "2024-07-02", "completion_date": "2029-01-16", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 17, "location_summary": "Anniston, Alabama • Fullerton, California • La Palma, California + 14 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Fullerton", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Lawrenceville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06293365" }, { "nct_id": "NCT02277106", "title": "Evaluate SAGE-547 in Participants With Essential Tremor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Essential Tremor" ], "interventions": [ { "name": "SAGE-547", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sage Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "35 Years to 75 Years" }, "enrollment_count": 25, "start_date": "2014-09-23", "completion_date": "2015-08-14", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 2, "location_summary": "Bingham Farms, Michigan • Raleigh, North Carolina", "locations": [ { "city": "Bingham Farms", "state": "Michigan" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02277106" }, { "nct_id": "NCT05428761", "title": "Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dehydration", "Rehydration", "Exercise Performance", "Exercise Recovery", "Fluid Balance", "Cognitive Performance" ], "interventions": [ { "name": "TP1", "type": "OTHER" }, { "name": "TP2", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Liquid I.V.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 16, "start_date": "2022-08-01", "completion_date": "2023-01-01", "has_results": false, "last_update_posted_date": "2023-01-25", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05428761" }, { "nct_id": "NCT04300296", "title": "PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris" ], "interventions": [ { "name": "secukinumab 300 mg Q4W", "type": "DRUG" }, { "name": "secukinumab 300 mg Q2W", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2020-07-27", "completion_date": "2022-05-03", "has_results": true, "last_update_posted_date": "2023-08-22", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Thousand Oaks, California • Cromwell, Connecticut + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04300296" }, { "nct_id": "NCT05428228", "title": "Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dehydration", "Rehydration", "Exercise Performance", "Exercise Recovery", "Cognitive Performance" ], "interventions": [ { "name": "TP1", "type": "OTHER" }, { "name": "TP2", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Liquid I.V.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 16, "start_date": "2022-10-01", "completion_date": "2024-09-01", "has_results": false, "last_update_posted_date": "2024-07-29", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05428228" }, { "nct_id": "NCT03441984", "title": "To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Treatment A", "type": "DRUG" }, { "name": "Treatment B", "type": "DRUG" }, { "name": "Treatment C", "type": "DRUG" }, { "name": "Treatment D", "type": "DRUG" }, { "name": "Treatment E", "type": "DRUG" }, { "name": "Treatment F", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 36, "start_date": "2018-02-26", "completion_date": "2018-04-28", "has_results": true, "last_update_posted_date": "2019-12-09", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03441984" }, { "nct_id": "NCT05108233", "title": "Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Malignant Head and Neck Neoplasm" ], "interventions": [ { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2022-01-01", "completion_date": "2025-12-01", "has_results": false, "last_update_posted_date": "2025-09-29", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05108233" }, { "nct_id": "NCT06918197", "title": "Evaluation the Impact of the \"Pas\" Technique Versus the \"Standard\" Technique on Radiation Exposure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spine", "Fluoroscopy for Spine Surgery", "Back Pain", "Sacroiliac Joint" ], "interventions": [ { "name": "PAS Technique", "type": "PROCEDURE" }, { "name": "Standard Technique", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Orthospine Advance Health, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 212, "start_date": "2023-10-01", "completion_date": "2024-05-15", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 1, "location_summary": "Merced, California", "locations": [ { "city": "Merced", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06918197" }, { "nct_id": "NCT00889382", "title": "A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Ovarian Cancer", "Solid Tumors" ], "interventions": [ { "name": "OSI-906", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 152, "start_date": "2009-08-05", "completion_date": "2014-08-25", "has_results": false, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-09-09T00:41:17.456Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Orange, California • Lafayette, Indiana + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Lafayette", "state": "Indiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Morristown", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00889382" } ] }